IL-6-mediated environmental conditioning of defective Th1 differentiation dampens antitumour immune responses in old age
暂无分享,去创建一个
[1] P. Nederlof,et al. Immune-Escape Markers in Relation to Clinical Outcome of Advanced Melanoma Patients Following Immunotherapy , 2014, Cancer Immunology Research.
[2] M. Ishii,et al. Characterization of the IL-15 niche in primary and secondary lymphoid organs in vivo , 2014, Proceedings of the National Academy of Sciences.
[3] M. Rothenberg,et al. Eosinophils and Cancer , 2014, Cancer Immunology Research.
[4] B. Fox,et al. Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells , 2013, European journal of immunology.
[5] L. Ferrucci,et al. Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy , 2013, The Journal of experimental medicine.
[6] B. Aggarwal,et al. Curcumin improves the therapeutic efficacy of Listeriaat-Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1 , 2013, Cancer medicine.
[7] C. Weyand,et al. Understanding immunosenescence to improve responses to vaccines , 2013, Nature Immunology.
[8] João Pedro de Magalhães,et al. How ageing processes influence cancer , 2013, Nature Reviews Cancer.
[9] S. Senju,et al. Myeloid-Derived Suppressor Cells Attenuate TH1 Development through IL-6 Production to Promote Tumor Progression , 2013, Cancer Immunology Research.
[10] Bernd Hauck,et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. , 2013, The New England journal of medicine.
[11] L. Zender,et al. T-helper-1-cell cytokines drive cancer into senescence , 2013, Nature.
[12] Jonathan B. Mitchem,et al. Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. , 2013, Cancer research.
[13] Robert M. DiFazio,et al. IFN-γ from CD4 T Cells Is Essential for Host Survival and Enhances CD8 T Cell Function during Mycobacterium tuberculosis Infection , 2013, The Journal of Immunology.
[14] U. V. von Andrian,et al. CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation. , 2012, Immunity.
[15] Michael Tighe,et al. The aged microenvironment contributes to the age‐related functional defects of CD4 T cells in mice , 2012, Aging cell.
[16] Suzanne R. Thibodeaux,et al. Mitigating age-related immune dysfunction heightens the efficacy of tumor immunotherapy in aged mice. , 2012, Cancer research.
[17] Steven A. Rosenberg,et al. Adoptive immunotherapy for cancer: harnessing the T cell response , 2012, Nature Reviews Immunology.
[18] C. Sautès-Fridman,et al. The immune contexture in human tumours: impact on clinical outcome , 2012, Nature Reviews Cancer.
[19] Naveena Singh,et al. Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer , 2011, Clinical Cancer Research.
[20] I. Donaldson,et al. Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer , 2011, Nature communications.
[21] L. Sherman,et al. CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes. , 2010, Cancer research.
[22] S. Swain,et al. Bim Dictates Naive CD4 T Cell Lifespan and the Development of Age-Associated Functional Defects , 2010, The Journal of Immunology.
[23] E. Wherry,et al. Cell-Intrinsic Defects in the Proliferative Response of Antiviral Memory CD8 T Cells in Aged Mice upon Secondary Infection , 2010, The Journal of Immunology.
[24] N. Watanabe,et al. c‐Maf activates the promoter and enhancer of the IL‐21 gene, and TGF‐β inhibits c‐Maf‐induced IL‐21 production in CD4+ T cells , 2010, Journal of leukocyte biology.
[25] P. Muranski,et al. Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma , 2010, The Journal of experimental medicine.
[26] Peter Olson,et al. Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. , 2010, Cancer cell.
[27] L. S. Quinn,et al. Serum and muscle interleukin-15 levels decrease in aging mice: Correlation with declines in soluble interleukin-15 receptor alpha expression , 2010, Experimental Gerontology.
[28] S. Swain,et al. Age-associated increase in lifespan of naïve CD4 T cells contributes to T-cell homeostasis but facilitates development of functional defects , 2009, Proceedings of the National Academy of Sciences.
[29] A. Iwasaki,et al. CTL mobilization to virus-infected tissue requires CD4+ T cell help , 2009, Nature.
[30] S. Giovannini,et al. Changes in IL-15 expression and death-receptor apoptotic signaling in rat gastrocnemius muscle with aging and life-long calorie restriction , 2009, Mechanisms of Ageing and Development.
[31] C. Caruso,et al. Inflammation, ageing and cancer , 2009, Mechanisms of Ageing and Development.
[32] S. Anton,et al. Molecular inflammation: Underpinnings of aging and age-related diseases , 2009, Ageing Research Reviews.
[33] A. Iwasaki,et al. CTL mobilization to virus-infected tissue requires CD4+ T cell help , 2009, Nature.
[34] Y. Belkaid,et al. Functional Regulatory T Cells Accumulate in Aged Hosts and Promote Chronic Infectious Disease Reactivation1 , 2008, The Journal of Immunology.
[35] Jianhong Cao,et al. Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. , 2008, The New England journal of medicine.
[36] A. Merrill,et al. Aging Up-Regulates Expression of Inflammatory Mediators in Mouse Adipose Tissue1 , 2007, The Journal of Immunology.
[37] E. Cevenini,et al. Age-dependent modifications of Type 1 and Type 2 cytokines within virgin and memory CD4+ T cells in humans , 2006, Mechanisms of Ageing and Development.
[38] E. Gardner,et al. Age-related changes in the immune response to influenza vaccination in a racially diverse, healthy elderly population. , 2006, Vaccine.
[39] S. Bandinelli,et al. CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC only. TRIALS The , 2004 .
[40] J. Ochando,et al. IL-6 Plays a Unique Role in Initiating c-Maf Expression during Early Stage of CD4 T Cell Activation1 , 2005, The Journal of Immunology.
[41] J. Berzofsky,et al. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function , 2005, The Journal of experimental medicine.
[42] P. Allen,et al. No Intrinsic Deficiencies in CD8+ T Cell-Mediated Antitumor Immunity with Aging1 , 2004, The Journal of Immunology.
[43] S. Senju,et al. Enhanced Priming of Antigen-Specific CTLs In Vivo by Embryonic Stem Cell-Derived Dendritic Cells Expressing Chemokine Along with Antigenic Protein: Application to Antitumor Vaccination1 , 2004, The Journal of Immunology.
[44] M. Lyon,et al. A dominant mutation within the DNA-binding domain of the bZIP transcription factor Maf causes murine cataract and results in selective alteration in DNA binding. , 2003, Human molecular genetics.
[45] J. Kirkwood,et al. Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4+ T Cell Responses Against MAGE-6 in HLA-DRB10401+ Patients With Renal Cell Carcinoma or Melanoma , 2002, The Journal of experimental medicine.
[46] Z. Cai,et al. Early Antigen-Specific Response by Naive CD8 T Cells Is Not Altered with Aging1 , 2002, The Journal of Immunology.
[47] L. Glimcher,et al. Transcription: tantalizing times for T cells. , 2002, Cell.
[48] E. Fikrig,et al. Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. , 2000, Immunity.
[49] T. Kita,et al. Altered Th1/Th2 commitment in human CD4+ T cells with ageing , 2000, Clinical and experimental immunology.
[50] S. Swain,et al. Interleukin 2, but Not Other Common γ Chain–Binding Cytokines, Can Reverse the Defect in Generation of Cd4 Effector T Cells from Naive T Cells of Aged Mice , 1999, The Journal of experimental medicine.
[51] L. Glimcher,et al. c-maf Promotes T Helper Cell Type 2 (Th2) and Attenuates Th1 Differentiation by Both Interleukin 4–dependent and –independent Mechanisms , 1998, The Journal of experimental medicine.
[52] C. Melief,et al. Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors , 1998, The Journal of experimental medicine.
[53] Y. Iwakura,et al. Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. , 1997, Journal of immunology.
[54] E. Wolf,et al. The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL- 6 and prolongation of the plasma half-life of IL-6 , 1996, The Journal of experimental medicine.
[55] K. Rock,et al. Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity , 1995, Nature Medicine.
[56] M. Passeri,et al. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. , 1993, Blood.